ProShare Advisors’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-21,203
| Closed | -$893K | – | 1877 |
|
|
2023
Q2 | $893K | Buy |
21,203
+7,924
| +60% | +$320K | ﹤0.01% | 753 |
|
|
2023
Q1 | $473K | Sell |
13,279
-3,133
| -19% | -$114K | ﹤0.01% | 933 |
|
|
2022
Q4 | $602K | Buy |
16,412
+531
| +3% | +$21K | ﹤0.01% | 877 |
|
|
2022
Q3 | $749K | Buy |
15,881
+575
| +4% | +$37.1K | ﹤0.01% | 786 |
|
|
2022
Q2 | $1.1M | Sell |
15,306
-5,807
| -28% | -$425K | ﹤0.01% | 746 |
|
|
2022
Q1 | $1.71M | Sell |
21,113
-5,457
| -21% | -$462K | ﹤0.01% | 756 |
|
|
2021
Q4 | $2.73M | Sell |
26,570
-5,148
| -16% | -$494K | 0.01% | 698 |
|
|
2021
Q3 | $2.77M | Buy |
31,718
+1,658
| +6% | +$150K | 0.01% | 646 |
|
|
2021
Q2 | $2.69M | Buy |
30,060
+7,702
| +34% | +$651K | 0.01% | 659 |
|
|
2021
Q1 | $1.7M | Sell |
22,358
-1,001
| -4% | -$75.5K | 0.01% | 755 |
|
|
2020
Q4 | $1.59M | Buy |
23,359
+765
| +3% | +$47.7K | 0.01% | 705 |
|
|
2020
Q3 | $1.2M | Buy |
22,594
+804
| +4% | +$47.9K | 0.01% | 671 |
|
|
2020
Q2 | $1.27M | Buy |
21,790
+432
| +2% | +$23.2K | 0.01% | 648 |
|
|
2020
Q1 | $842K | Sell |
21,358
-16,294
| -43% | -$953K | 0.01% | 625 |
|
|
2019
Q4 | $2.24M | Sell |
37,652
-3,583
| -9% | -$193K | 0.01% | 597 |
|
|
2019
Q3 | $2.19M | Sell |
41,235
-1,966
| -5% | -$101K | 0.01% | 566 |
|
|
2019
Q2 | $2.21M | Sell |
43,201
-6,117
| -12% | -$285K | 0.01% | 568 |
|
|
2019
Q1 | $2.55M | Buy |
49,318
+1,955
| +4% | +$94.8K | 0.02% | 550 |
|
|
2018
Q4 | $1.86M | Sell |
47,363
-9,352
| -16% | -$435K | 0.01% | 587 |
|
|
2018
Q3 | $2.92M | Buy |
56,715
+101
| +0.2% | +$4.95K | 0.02% | 532 |
|
|
2018
Q2 | $2.65M | Sell |
56,614
-4,924
| -8% | -$204K | 0.02% | 566 |
|
|
2018
Q1 | $2.19M | Sell |
61,538
-9,171
| -13% | -$359K | 0.01% | 599 |
|
|
2017
Q4 | $3.08M | Buy |
70,709
+3,717
| +6% | +$174K | 0.02% | 527 |
|
|
2017
Q3 | $3.5M | Buy |
66,992
+30,654
| +84% | +$1.71M | 0.03% | 445 |
|
|
2017
Q2 | $2.13M | Buy |
36,338
+2,749
| +8% | +$143K | 0.02% | 537 |
|
|
2017
Q1 | $1.54M | Sell |
33,589
-8,485
| -20% | -$422K | 0.02% | 626 |
|
|
2016
Q4 | $2.21M | Buy |
42,074
+3,632
| +9% | +$176K | 0.02% | 520 |
|
|
2016
Q3 | $1.71M | Sell |
38,442
-6,984
| -15% | -$303K | 0.02% | 531 |
|
|
2016
Q2 | $1.73M | Buy |
45,426
+3,885
| +9% | +$171K | 0.02% | 563 |
|
|
2016
Q1 | $1.71M | Sell |
41,541
-5,770
| -12% | -$238K | 0.02% | 503 |
|
|
2015
Q4 | $2.29M | Buy |
+47,311
| New | +$2.1M | 0.03% | 463 |
|
Other funds holding SYNH
IA
BTI
CFB
HNB
ProShare Advisors's SYNH Position: Q3 2023 in Review
ProShare Advisors sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 21,203 shares — an estimated $893K sold.
ProShare Advisors first reported a position in SYNH in Q4 2015 and held it in 31 quarters. The position peaked at $3.5M in Q3 2017. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.
- ProShare Advisors reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
- ProShare Advisors sold 21,203 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $893K.
- ProShare Advisors first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2015 and held it in 31 quarters.
- ProShare Advisors's Syneos Health, Inc. Class A Common Stock position peaked at $3.5M in Q3 2017.
- 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.
Based on ProShare Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.